On September 23, 2026, China Pharmaceutical Company Limited acquired 1.25 million shares of SSY GROUP (02005) off-exchange at an average price of HKD 2.797 per share, involving approximately HKD 3.50 million. This was an off-exchange transaction (not matched on the SEHK open market) and therefore not a direct secondary-market dealing.
Prior to the acquisition, China Pharmaceutical Company Limited's long position in SSY GROUP was 921.45 million shares, representing 31.22% of the issued shares; following the acquisition, the holding changed to 922.70 million shares, with the long position ratio rising to 31.26%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments